MDP — Medexus Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSuper Stock

Annual balance sheet for Medexus Pharmaceuticals, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	R2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	5.23	18.7	10	13.1	5.25
Net Total Accounts Receivable
Net Total Receivables	15	18.8	14.4	22.4	24
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	39.7	58.6	49.1	73	72.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.1	0.795	1.22	0.899	0.778
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	123	149	139	161	156
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	34.2	39.9	48.1	83.5	66.2
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	98.5	130	121	139	125
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	24.3	18	17.8	22.4	30.3
Total Liabilities & Shareholders' Equity	123	149	139	161	156
Total Common Shares Outstanding